Evidence map›Paper›PMID 35164262›Full record

ArticleMolecules (Basel, Switzerland)2022

Semi-Quantitative MALDI Measurements of Blood-Based Samples for Molecular Diagnostics.

Matthew A Koc, Senait Asmellash, Patrick Norman, Steven Rightmyer, Joanna Roder, Robert W Georgantas, Heinrich Roder

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthew A KocBiodesix Inc., Boulder, CO 80301, USA.ORCID 0000-0003-1401-8415
Senait AsmellashBiodesix Inc., Boulder, CO 80301, USA.
Patrick NormanBiodesix Inc., Boulder, CO 80301, USA.
Steven RightmyerBiodesix Inc., Boulder, CO 80301, USA.
Joanna RoderBiodesix Inc., Boulder, CO 80301, USA.
Robert W GeorgantasBiodesix Inc., Boulder, CO 80301, USA.
Heinrich RoderBiodesix Inc., Boulder, CO 80301, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate and precise measurement of the relative protein content of blood-based samples using mass spectrometry is challenging due to the large number of circulating proteins and the dynamic range of their abundances. Traditional spectral processing methods often struggle with accurately detecting overlapping peaks that are observed in these samples. In this work, we develop a novel spectral processing algorithm that effectively detects over 1650 peaks with over 3.5 orders of magnitude in intensity in the 3 to 30 kD m/z range. The algorithm utilizes a convolution of the peak shape to enhance peak detection, and accurate peak fitting to provide highly reproducible relative abundance estimates for both isolated peaks and overlapping peaks. We demonstrate a substantial increase in the reproducibility of the measurements of relative protein abundance when comparing this processing method to a traditional processing method for sample sets run on multiple matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) instruments. By utilizing protein set enrichment analysis, we find a sizable increase in the number of features associated with biological processes compared to previously reported results. The new processing method could be very beneficial when developing high-performance molecular diagnostic tests in disease indications.

Indexed as

BloodAlgorithmsHumansMolecular Diagnostic TechniquesReproducibility of ResultsSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionizationmass spectrometrypeak detectionproteomicsset enrichment analysisspectral processing

Identifiers

PMID35164262
PMCPMC8840133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.